chrX-38352758-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000531.6(OTC):āc.62T>Cā(p.Met21Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000367 in 1,089,535 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M21V) has been classified as Likely benign.
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.62T>C | p.Met21Thr | missense_variant | 1/10 | ENST00000039007.5 | |
OTC | NM_001407092.1 | c.62T>C | p.Met21Thr | missense_variant | 3/12 | ||
OTC | XM_017029556.2 | c.62T>C | p.Met21Thr | missense_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.62T>C | p.Met21Thr | missense_variant | 1/10 | 1 | NM_000531.6 | P1 | |
OTC | ENST00000488812.1 | n.154T>C | non_coding_transcript_exon_variant | 1/6 | 5 | ||||
OTC | ENST00000643344.1 | c.62T>C | p.Met21Thr | missense_variant, NMD_transcript_variant | 1/11 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183020Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67558
GnomAD4 exome AF: 0.00000367 AC: 4AN: 1089535Hom.: 0 Cov.: 27 AF XY: 0.00000563 AC XY: 2AN XY: 355201
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Dec 01, 2023 | - - |
OTC-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 07, 2023 | The OTC c.62T>C variant is predicted to result in the amino acid substitution p.Met21Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0073% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/X-38212011-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at